Browse by Nurse Practitioner Items

Nurse practitioner PBS prescribing

MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS

From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners) Information for nurse practitioners to become authorised PBS prescribers is available from Medicare Australia.

The medicines listed for prescribing by authorised nurse practitioners are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.

PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.

The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health and Ageing regarding medicines for prescribing by authorised nurse practitioners.

Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:

  • Continuing therapy only model

Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)

  • Shared care model

Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.

Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.

Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.

Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms.  For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms.  Nurse practitioner PBS prescriptions may include repeats. 

Regulation 24 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.

Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from Medicare Australia for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)

State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.

Legend
MP
Medical Practitioner
MW
Midwife
NP
Nurse Practitioner
Prescriber
Code
Item Code Name, manner of administration and form & strength Max Quantity No. of repeats Pack size
MPNP 1004W ACETAZOLAMIDE
Tablet 250 mg
100 3 100
MPNP 1003T ACICLOVIR
Tablet 200 mg
50 0 25
MPNP 1007B ACICLOVIR
Tablet 200 mg
90 5 90
MPNP 1052J ACICLOVIR
Tablet 800 mg
35 0 35
MPNP 1002R ACICLOVIR
Eye ointment 30 mg per g (3%), 4.5 g
1 0 1
MPNP 1016L ADRENALINE
Injection 1 mg in 1 mL (1 in 1,000)
5 1 5
MPNP 3451P ADRENALINE
Injection 1 mg in 1 mL (1 in 1,000)
5 0 5
MPNP 3408J ADRENALINE
I.M. injection 150 micrograms in 0.3 mL single dose syringe auto-injector
1 0 1
MPNP 3409K ADRENALINE
I.M. injection 300 micrograms in 0.3 mL single dose syringe auto-injector
1 0 1
MPNP 2600W ALLOPURINOL
Tablet 100 mg
200 2 100
MPNP 2604C ALLOPURINOL
Tablet 300 mg
60 2 60
MPNP 2130D ALPRAZOLAM
Tablet 250 micrograms
50 0 50
MPNP 2131E ALPRAZOLAM
Tablet 500 micrograms
50 0 50
MPNP 2132F ALPRAZOLAM
Tablet 1 mg
50 2 50
MPNP 2157M ALUMINIUM HYDROXIDE with MAGNESIUM HYDROXIDE
Oral suspension 200 mg-200 mg per 5 mL, 500 mL
2 5 1
MPNP 2159P ALUMINIUM HYDROXIDE with MAGNESIUM TRISILICATE and MAGNESIUM HYDROXIDE
Oral suspension 250 mg-120 mg-120 mg per 5 mL, 500 mL
2 5 1
MPNP 3016R AMANTADINE HYDROCHLORIDE
Capsule 100 mg
100 5 100
MPNP 3417W AMINO ACID FORMULA with FAT, CARBOHYDRATE, VITAMINS, MINERALS, and TRACE ELEMENTS, without METHIONINE and supplemented with DOCOSAHEXANOIC ACID
Oral liquid 125 mL, 36
4 5 1
MPNP 2650L AMINO ACID FORMULA with VITAMINS and MINERALS without LYSINE and low in TRYPTOPHAN
Infant formula, powder 400 g
8 5 1
MPNP 2646G AMINO ACID FORMULA with VITAMINS and MINERALS without LYSINE and low in TRYPTOPHAN
Powder 500 g
8 5 1
MPNP 3443F AMINO ACID FORMULA with VITAMINS and MINERALS without METHIONINE, THREONINE and VALINE and low in ISOLEUCINE
Sachets 25 g, 30
4 5 1
MPNP 3444G AMINO ACID FORMULA with VITAMINS and MINERALS without METHIONINE, THREONINE and VALINE and low in ISOLEUCINE
Sachets 24 g, 30
4 5 1
MPNP 1411G AMINO ACID FORMULA with VITAMINS and MINERALS without PHENYLALANINE
Sachets 18.2 g, 60
3 5 1
MPNP 2738D AMINO ACID FORMULA with VITAMINS and MINERALS without PHENYLALANINE
Powder 500 g
8 5 1
MPNP 2739E AMINO ACID FORMULA with VITAMINS and MINERALS without PHENYLALANINE
Powder 500 g
8 5 1
MPNP 2382J AMINO ACID FORMULA with VITAMINS and MINERALS without PHENYLALANINE
Oral liquid 87 mL, 30
4 5 1
MPNP 2474F AMINO ACID FORMULA with VITAMINS and MINERALS without PHENYLALANINE
Oral liquid 174 mL, 30
4 5 1
MPNP 3078B AMINO ACID FORMULA with VITAMINS and MINERALS without PHENYLALANINE and TYROSINE
Powder 500 g
8 5 1
MPNP 2380G AMINO ACID FORMULA with VITAMINS and MINERALS without VALINE, LEUCINE and ISOLEUCINE
Infant formula, powder 400 g
8 5 1
MPNP 2375B AMINO ACID FORMULA with VITAMINS and MINERALS without VALINE, LEUCINE and ISOLEUCINE
Oral liquid 130 mL, 30
4 5 1
MPNP 2347M AMINO ACID FORMULA without PHENYLALANINE
Sachets containing powder 20 g, 30
7 5 1
MPNP 2246F AMINO ACID SYNTHETIC FORMULA supplemented with LONG CHAIN POLYUNSATURATED FATTY ACIDS
Compound powder 400 g
8 5 1
MPNP 2560R AMINO ACID SYNTHETIC FORMULA supplemented with LONG CHAIN POLYUNSATURATED FATTY ACIDS
Compound powder 400 g
8 5 1
MPNP 2250K AMINO ACIDS—SYNTHETIC, FORMULA
Compound powder 400 g
12 5 1
MPNP 2244D AMINO ACIDS—SYNTHETIC, FORMULA
Compound powder 400 g
8 5 1
MPNP 3066J AMINO ACIDS—SYNTHETIC, FORMULA
Compound powder 400 g
8 5 1
MPNP 2553J AMINO ACIDS—SYNTHETIC, FORMULA
Compound powder 400 g
8 5 1
MPNP 2344J AMIODARONE
Tablet containing amiodarone hydrochloride 100 mg
30 5 30
MPNP 2343H AMIODARONE
Tablet containing amiodarone hydrochloride 200 mg
30 5 30
MPNP 2417F AMITRIPTYLINE HYDROCHLORIDE
Tablet 10 mg
50 2 50
MPNP 2418G AMITRIPTYLINE HYDROCHLORIDE
Tablet 25 mg
50 2 50
MPNP 2429W AMITRIPTYLINE HYDROCHLORIDE
Tablet 50 mg
50 2 50
MPNP 2751T AMLODIPINE
Tablet 5 mg (as besylate)
30 5 30
MPNP 1343Q AMLODIPINE
Tablet 5 mg (as maleate)
30 5 30
MPNP 2752W AMLODIPINE
Tablet 10 mg (as besylate)
30 5 30
MPNP 1345T AMLODIPINE
Tablet 10 mg (as maleate)
30 5 30
MPMWNP 1884E AMOXYCILLIN
Capsule 250 mg
20 1 20
MPMWNP 1889K AMOXYCILLIN
Capsule 500 mg
20 1 20
MPNP 1878W AMOXYCILLIN
Sachet containing oral powder 3 g
1 0 1
MPNP 1888J AMOXYCILLIN
Powder for paediatric oral drops 100 mg per mL, 20 mL
1 1 1
MPNP 1886G AMOXYCILLIN
Powder for syrup 125 mg per 5 mL, 100 mL
1 1 1
MPNP 1887H AMOXYCILLIN
Powder for syrup 250 mg per 5 mL, 100 mL
1 1 1
MPMWNP 1891M AMOXYCILLIN with CLAVULANIC ACID
Tablet 500 mg-125 mg
10 1 10
MPNP 1892N AMOXYCILLIN with CLAVULANIC ACID
Powder for syrup 125 mg-31.25 mg per 5 mL, 75 mL
1 1 1
MPNP 2931G AMPHOTERICIN
Lozenge 10 mg
20 1 20
MPNP 2390T AMPICILLIN
Powder for injection 500 mg
5 1 5
MPNP 2977Q AMPICILLIN
Powder for injection 1 g
5 1 5
MPNP 5054B APIXABAN
Tablet 2.5 mg
30 0 30
MPNP 5061J APIXABAN
Tablet 2.5 mg
60 0 60
MPNP 5140M ASENAPINE
Sublingual wafer 5 mg (as maleate)
60 5 60
MPNP 5141N ASENAPINE
Sublingual wafer 10 mg (as maleate)
60 5 60
MPNP 1010E ASPIRIN
Tablet 300 mg (dispersible)
96 1 96
MPNP 1081X ATENOLOL
Tablet 50 mg
30 5 30
MPNP 1089H ATROPINE
Injection containing atropine sulfate 600 micrograms in 1 mL
10 1 10
MPNP 3453R ATROPINE
Injection containing atropine sulfate 600 micrograms in 1 mL
10 0 10
MPNP 1093M ATROPINE
Eye drops containing atropine sulfate 10 mg per mL (1%), 15 mL
1 2 1
MPNP 1095P AURANOFIN
Tablet 3 mg
60 5 60
MPNP 2688L AZATHIOPRINE
Tablet 25 mg
100 2 100
MPNP 2687K AZATHIOPRINE
Tablet 50 mg
100 2 100